FdaApplication

NDA 205551

Back to search

Identifiers

Properties

PropertyValue
applicant_nameVIIV HEALTHCARE CO
application_typeNDA
approval_date2014-08-22

Products (1)

ProductActive ingredientStrengthDosage form
TRIUMEQABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINEEQ 600MG BASE;EQ 50MG BASE;300MGTABLET;ORAL

1 product